Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects
Oncology Research · Yu Chang, Na Qiao, Qingqing Wang et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects?
- Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects was written by Yu Chang, Na Qiao, Qingqing Wang, Chan Bao.
- When was Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects first published?
- Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects was first published in 2026.
Sources
Last updated · facts checked 13 November 2026
Cite this page
"Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects". DigiNepal. Last updated 13 November 2026. https://diginpl.com/books/paper-or-2026-089420. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.089420.